SEC Filing Details
Document Details
Form
Filing Date
Feb 4, 2022
Document Date
Feb 4, 2022
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Lexeo Therapeutics
Issuer
LEXEO THERAPEUTICS, INC.
Contact Us
-
Investor Inquiries -
Media Inquiries
